ArticleArquivos brasileiros de oftalmologia2025
Quality of life and treatment adherence in glaucoma: a cross-sectional analysis using the NEI-VFQ25 and MMAS-8 questionnaires.
Article in Arquivos brasileiros de oftalmologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo analyze the quality of life and treatment adherence of patients with glaucoma at different disease stages, considering factors such as sex, visual acuity, disease severity, and treatment characteristics.
methodsThis cross-sectional study included 174 patients (346 glaucomatous eyes) recruited from clinical records and routine follow-ups at a specialized ophthalmology center. Their mean age was 39-90 years, and 60.9% of them were women. Their quality of life and adherence were assessed using the NEI-VFQ25 and MMAS-8 questionnaires, respectively. Complementary tests included 24:2 visual field test, retinography, and optical coherence tomography. Patients diagnosed with glaucoma for at least 6 months were included, whereas pregnant patients and those with ocular diseases were excluded.
resultsAmong the participants, 59.2% adhered to the treatment whereas 40.8% showed low adherence. The mean quality of life score was 81.87. Patients with low adherence had slightly higher quality of life scores (mean 83.1) than those with good adherence (mean 81.0), but the difference was not statistically significant. Disease severity was associated with increased optic nerve cupping, reduced thickness of the nerve fiber and ganglion cell layers, and great visual field loss. No significant correlation was observed between adherence and quality of life, indicating the independence of these factors and the influence of psychological or social elements.
conclusionThe absence of a correlation between quality of life and treatment adherence highlights the need for tailored interventions for psychological and social aspects. These findings indicate the importance of a comprehensive approach to managing glaucoma, preserving visual function, strengthening doctor-patient relationships, and considering psychosocial factors to enhance quality of life and treatment adherence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.